Kawada Manabu

カワダマナブ | Kawada Manabu

Affiliation and department：
Job title： Chief Researcher
Other affiliations (1)：

Homepage URL (1)： http://www.bikaken.or.jp/

Research field (1)： Cell biology

Research keywords (2)： Anti-cancer drug , Tumor-stromal cell interactions

Research theme for competitive and other funds (14)：

2022 - 2028 先端モデル動物支援プラットフォーム
2016 - 2021 先端モデル動物支援プラットフォーム
2015 - 2018 Development and mechanism analysis of small molecules affecting tumor-stromal cell interactions
2010 - 2016 Scientific Support Programs for Cancer Research Grant-in-Aid for Scientific Research on Innovative Areas
2011 - 2013 がん微小環境を制御する低分子プローブの開発

Show all

Papers (153)：

Kenichiro Ishikawa, Hiroyuki Suzuki, Tomokazu Ohishi, Takuro Nakamura, Miyuki Yanaka, Guanjie Li, Tomohiro Tanaka, Akira Ohkoshi, Manabu Kawada, Mika Kaneko, et al. Antitumor activities of anti-CD44 monoclonal antibodies in mouse xenograft models of esophageal cancer. Oncology Reports. 2024. 52. 5
Kenichiro Ishikawa, Hiroyuki Suzuki, Tomokazu Ohishi, Guanjie Li, Tomohiro Tanaka, Manabu Kawada, Akira Ohkoshi, Mika K. Kaneko, Yukio Katori, Yukinari Kato. Anti-CD44 Variant 10 Monoclonal Antibody Exerts Antitumor Activity in Mouse Xenograft Models of Oral Squamous Cell Carcinomas. International Journal of Molecular Sciences. 2024. 25. 17. 9190-9190
Daisuke Tatsuda, Masahide Amemiya, Chisato Nosaka, Ryuichi Sawa, Hideyuki Muramatsu, Masayuki Igarashi, Junjiro Yoshida, Tomokazu Ohishi, Manabu Kawada. Two new adenopeptins B and C inhibit sphere formation of pancreatic cancer cells. The Journal of antibiotics. 2023
Hiroyuki Suzuki, Tomokazu Ohishi, Ren Nanamiya, Manabu Kawada, Mika K Kaneko, Yukinari Kato. Defucosylated Monoclonal Antibody (H2Mab-139-mG2a-f) Exerted Antitumor Activities in Mouse Xenograft Models of Breast Cancers against Human Epidermal Growth Factor Receptor 2. Current issues in molecular biology. 2023. 45. 10. 7734-7748
Daisuke Tatsuda, Junjiro Yoshida, Tomokazu Ohishi, Manabu Kawada. Pancreatic Stromal Cell-derived Oncostatin M Confers Drug Resistance to a Multi-tyrosine Kinase Inhibitor in Pancreatic Cancer Cells. Anticancer research. 2023. 43. 6. 2477-2489

ｍore...

MISC (71)：

大石智一, 川田学. Involvement of the fibrinolytic system regulator in the liver metastasis of colorectal cancer. 日本がん転移学会学術集会・総会プログラム抄録集. 2021. 30th
田中智大, 大石智一, 川田学, 金子美華, 加藤幸成. 抗TROP2モノクローナル抗体TrMab-6の乳がんモデルに対する抗腫瘍効果. 日本癌学会学術総会抄録集(Web). 2021. 80th
細野ヒデキ, 大石智一, 淺野禎三, 金子美華, 川田学, 加藤幸成, 加藤幸成. 新規抗EpCAM抗体(EpMab-16)の大腸がんに対する抗腫瘍活性の評価. 日本生化学会大会(Web). 2021. 94th
大石智一, 加藤幸成, 大庭俊一, 川田学. Novel anti-EGFR monoclonal antibody EMab-17 exerts anti-tumor activity for colon cancer. 日本がん分子標的治療学会学術集会プログラム・抄録集. 2021. 25th
七宮蓮, 武井潤子, 武井潤子, 大石智一, 川田学, 原田浩之, 金子美華, 加藤幸成, 加藤幸成. 新規抗EGFRモノクローナル抗体134-mG2aの口腔扁平上皮がん移植片モデルにおける抗腫瘍効果の検討. 日本癌学会学術総会抄録集(Web). 2021. 80th

ｍore...

Professional career (1)：

Committee career (3)：

Awards (4)：

Association Membership(s) (5)：

日本がん転移学会 , 日本がん分子標的治療学会 , 日本生化学会 , 日本癌学会 , American Society for Biochemistry and Molecular Biology

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page